IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 18 (6) , 2515-2526
Abstract
Rationale: In multiple myeloma (MM), the activities of non-homologous end joining (NHEJ) and homologous recombination repair (HR) are increased compared with healthy controls. Whether and how IKZF1 as an enhancer of MM participates in the DNA repair pathway of tumor cells remains elusive.Keywords
This publication has 44 references indexed in Scilit:
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros ProteinsScience, 2014
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma CellsScience, 2014
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib ResistanceCancer Cell, 2012
- IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic LeukemiaPLOS ONE, 2012
- Non‐Homologous End‐Joining Gene Profiling Reveals Distinct Expression Patterns Associated with Lymphoma and Multiple MyelomaBritish Journal of Haematology, 2010
- Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by IkarosNature Immunology, 2008
- Regulation of DNA double-strand break repair pathway choiceCell Research, 2007
- Ikaros-CtIP Interactions Do Not Require C-terminal Binding Protein and Participate in a Deacetylase-independent Mode of RepressionJournal of Biological Chemistry, 2002
- Haematopoietic cell-fate decisions, chromatin regulation and ikarosNature Reviews Immunology, 2002
- Interferon-α Signaling Promotes Nucleus-to-Cytoplasmic Redistribution of p95Vav, and Formation of a Multisubunit Complex Involving Vav, Ku80, and Tyk2Biochemical and Biophysical Research Communications, 2000